Dr. Taylor was a panelist for the Forum’s discussion on Organ Transplantation.
Dr. Doris A. Taylor is the Director of Regenerative Medicine Research at the Texas Heart Institute (THI). Before joining THI, Dr. Taylor directed the Center for Cardiovascular Repair at the University of Minnesota (UMN). She also held academic appointments as the Medtronic Bakken Chair of Integrative Biology and Physiology and Professor of Medicine at UMN. Taylor received her Ph.D. in Pharmacology from the UT Southwestern Medical Center and did her postdoctoral training in Molecular Biology at Albert Einstein College of Medicine, Bronx, New York. She was on the faculty in Cardiology at Duke University Medical Center for twelve years.
Dr. Taylor is a pioneer in cell therapy and organ engineering. She is the PI of one of the AHA Jon Holden DeHaan Cardiac Myogenesis Research centers and is the Co-PI/Director of the National Heart Lung and Blood Institute (NHLBI) Cardiovascular Cell Therapy Research Network (CCTRN)Biorepository and Cell Profiling Core Lab. Among other research responsibilities, Dr. Taylor is currently on the advisory board to the International Society for Heart & Lung Transplantation (ISHLT) Basic Science/Translational Research Council and on the scientific committee and sits on the jury of the Grand Prix Lefoulon-Delalande Foundation at the Institut de France, which awards a half-million euro prize yearly to a scientist with the greatest impact on the treatment of cardiovascular disease.
Dr. Taylor is committed to moving cell, gene, and tissue engineering-based therapies safely and effectively from bench to bedside, while at the same time preparing students and fellows to compete at an international level in the field of cardiac and vascular repair and regeneration. Her goal is two-fold: creation of cutting edge therapies for chronic disease and the education of scientists, physician scientists and the community in the “treatments of tomorrow” for these diseases.
